Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.

ICICI Prudential Mutual Fund

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option

★★★★★ 3rd-party

External rating

  • Source: Third-party data provider (Groww/CRISIL)
  • Original rating: 4/5, displayed as-is — TopFund does not modify third-party ratings
  • Refresh frequency: Whenever TopFund re-syncs this fund's data
  • Limitations: The provider's own rating methodology isn't disclosed here — see the provider's own site for their criteria

Full rating methodology →

TopFund Score: 80/100 · Excellent

How this score is calculated

  • Star rating (35%)4/5
  • 3Y CAGR (30%)22.7%
  • Expense ratio (20%)1.29%
  • AUM (15%)₹6,861 Cr

Not investment advice — an analytical read of public fund data. Methodology →

ICICI Prudential Mutual Fund · Equity · Sectoral

₹47.37

+0.0 (+0.0%)

AUM: ₹6,861 Cr

NAV updated 14 days ago

Plan

Direct

Option

Growth

Risk

Very High

Expense Ratio

1.29%

Exit Load

Exit load of 1% if redeemed within 15 days.

Fund Manager

Ihab Dalwai, Priyanka Khandelwal

Inception

Jul 2018

Benchmark

BSE Healthcare Total Return Index

Sharpe Ratio

0.19

Std Dev (1Y)

13.74%

Historical Returns (CAGR)

Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.

1m

+3.0%

3m

-0.59%

6m

+5.81%

1y

+7.63%

3y

+22.7%

5y

+17.19%

10y

—

since inception

+20.73%

TopFund's Take on ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option ranks among the stronger performers in the Sectoral category, backed by a 4-star rating. Consistent 3-year performance combined with a strong rating makes this one of the more credible options in its space. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 80/100.

Cost: At 1.29%, the expense ratio runs 29% above the Sectoral category average of 1.0%. That gap is worth weighing against the fund's actual performance versus cheaper peers before committing to a long SIP.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a modest Sharpe ratio of 0.19 — returns have only marginally compensated for the risk taken. Separately, annualised volatility of 13.74% is fairly typical for Sectoral funds.

Who should invest: This fund is best suited to investors whose goals and risk appetite align with a Equity fund. Given the Very High risk rating, this fund is not suited to short-term goals or investors who may need to exit within 2-3 years.

This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.

Sector Allocation

Healthcare 96.64%
Materials 1.21%
Industrials 1.06%

Asset Allocation

Equity 98.91%
Repo 4.25%
Cash Margin 0.01%

Frequently Asked Questions about ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option

* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

No comments yet — start the discussion.